Scott Dunseth Myers Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading activity

Scott Dunseth Myers is Director of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 260,192 shares of ZNTL, which is worth approximately $806,595. The most recent transaction as insider was on Nov 13, 2024, when has been sold 260,192 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 260K

n/a 3M change

n/a 12M change

Total Value Held $806,595

Scott Dunseth Myers Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Nov 13 2024	BUY Grant, award, or other acquisition	-	260,192 Added 50.0%	260,192 Common Stock

Also insider at

AMAG

AMAG PHARMACEUTICALS, INC.

President & CEO

SELB

SELECTA BIOSCIENCES INC Healthcare

Director

HARP

Harpoon Therapeutics, Inc. Healthcare

DVAX

DYNAVAX TECHNOLOGIES CORP Healthcare

VRDN

Viridian Therapeutics, Inc.\DE Healthcare

Chief Executive Officer

SDM